Abstract
We present the case of a 33-year-old man, who was diagnosed with a cerebellar medulloblastoma in October 2000. Surgery with complete resection followed by craniospinal fractionated radiation therapy. The recurrences were treated according to HIT 2000 and the 3rd recurrence was treated by a metronomic anti-angiogenetic therapy. Technical advances in diagnostics, surgery and radiotherapy increased prognoses for patients with brain tumours. Case reports in the literature show encouraging results with second and third line chemotherapy, anti-angiogenic drugs and targeted therapy for example with somatostatin analogues. These therapies may further improve prognosis and enable "living with cancer" for years even for patients with fatal prognosis like disseminated spinal metastases of adult medulloblastoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
